Skip to main content

$0.037 (0%)

High

-

Low

-

Trades

-

Turnover

$0

Volume

0
6 July 2025 at 2:42pm
Register to track COO and receive email alerts.
Subject
COO Ann: Notification regarding unquoted securities - COO

COO Ann: Further Update on Legal Proceedings

COO Ann: Further update on legal proceedings

COO Ann: Further update on legal proceedings

COO Ann: Further Update on Legal Proceedings

COO Ann: Update on Legal Proceedings

COO Ann: Trading Halt

COO Ann: Results Release and Investor Presentation

COO Ann: Half Yearly Report and Accounts

COO Ann: Notice of Results Announcement

COO Ann: Notification regarding unquoted securities - COO

COO Ann: Update on Legal Proceedings relating to PharmX

COO Ann: Amendment to the Constitution

COO Ann: Results of Annual General Meeting

COO Ann: Chair's Presentation to the AGM

COO Ann: Application for quotation of securities - COO

COO Ann: Notice of Annual General Meeting/Proxy Form

COO Ann: Key AGM Dates

COO Ann: Investor Presentation FY22

COO Ann: FY22 Results Release

COO Ann: Appendix 4G and Corporate Governance Statement

COO Ann: Appendix 4E and Annual Report

COO Ann: PharmX Launches PharmXchange Platform

COO Ann: Sigma signs long term PharmX agreement

COO Ann: Notification of cessation of securities - COO

COO Ann: Corum completes sale of Real Estate eCommerce business unit

COO Ann: H1 FY22 Interim Media Release and Results Presentation

COO Ann: Half Yearly Report and Accounts

COO Ann: PharmX Agreement - Supplementary Information

COO Ann: Symbion & ProPharma sign long term PharmX agreement

COO Ann: Notice of Results Announcement

COO Ann: Notification of cessation of securities - COO

COO Ann: Final Director's Interest Notice - J Sallabank

COO Ann: Resignation of Managing Director

COO Ann: Corum Agrees Sale of eCommerce Business Unit

COO Ann: Notification regarding unquoted securities - COO

COO Ann: Trading Update

COO Ann: Update on Legal Proceedings relating to PharmX

COO Ann: Results of Annual General Meeting

COO Ann: Chairman & CEO Address and AGM Presentation

COO Ann: Key Retail Pharmacy Groups signed on to drive PharmX growth

COO Ann: Corum Trading Update

COO Ann: Notice of General Meeting/Proxy Form

COO Ann: 2021 Annual General Meeting Key Dates

COO Ann: Corum extends relationship with Sigma into WholeLife

COO Ann: Press Release and Investor Presentation

COO Ann: Appendix 4G and Corporate Governance Statement

COO Ann: Appendix 4E and Annual Report

COO Ann: Notice of Results Announcement and Investor Presentation

COO Ann: Investor Presentation

Register to track COO and receive email alerts.

Similar Companies

ALU
BRN
HSN
IRE
ISX
NEA
NXL
OCL
TNE
WTC